𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations

✍ Scribed by Maria I. Behrens; Norbert Brüggemann; Pedro Chana; Pablo Venegas; Marianne Kägi; Teresa Parrao; Patricia Orellana; Cristian Garrido; Cecilia V. Rojas; Jan Hauke; Eric Hahnen; Rafael González; Nicolas Seleme; Verónica Fernández; Alexander Schmidt; Ferdinand Binkofski; Detlef Kömpf; Christian Kubisch; Johann Hagenah; Christine Klein; Alfredo Ramirez

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
207 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We report the clinical features of the original Chilean family with Kufor‐Rakeb syndrome (KRS) that led to the discovery of the ATP13A2 gene at the PARK9 locus. KRS is a rare juvenile‐onset autosomal recessive disease characterized by progressive Parkinsonism, pyramidal signs, and cognitive decline in addition to vertical gaze palsy and facial‐faucial‐finger minimyoclonus. Neurological and neuropsychological examination during a 10‐year period, videotaping, neuroimaging, and measurement of DNA methylation of the ATP13A2 promoter region were performed. The youngest 5 of 17 children of nonconsanguineous parents, carrying compound‐heterozygous ATP13A2 mutations, had normal development until ages ∼10 to 12 years, when school performance deteriorated and slowness, rigidity, and frequent falls developed. Examination revealed bradykinesia, subtle postural/action tremor, cogwheel rigidity, spasticity, upward gaze palsy, smooth pursuit with saccadic intrusions, and dementia. Additional signs included facial‐faucial‐finger minimyoclonus, absent postural reflexes, visual/auditory hallucinations, and insomnia. Levodopa response could not be fully judged in this family. T2* magnetic resonance imaging sequences revealed marked diffuse hypointensity of the caudate (head and body) and lenticular nucleus bilaterally. Disease progression was slow including epilepsy, cachexia, and anarthria. Four affected members died after 28.5 ± 5.5 (mean ± SD) years of disease. Two heterozygous carriers, the mother and eldest sibling, showed jerky perioral muscle contractions and clumsiness of hand movements. There was no significant correlation between DNA methylation of the ATP13A2 promoter region and disease progression. The marked caudate and lenticular nucleus T2*‐hypointensity suggests that KRS might belong to the family of neurodegenerative diseases associated with brain iron accumulation. © 2010 Movement Disorder Society.

📜 SIMILAR VOLUMES

Pathogenic effects of novel mutations in
Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism
✍ Jin-Sung Park; Prachi Mehta; Antony A. Cooper; David Veivers; André Heimbach; Ba 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 450 KB 👁 1 views

Kufor-Rakeb syndrome (KRS) is a rare form of autosomal recessive juvenile or early-onset, levodopa responsive parkinsonism and has been associated with mutations in ATP13A2(also known as PARK9), a lysosomal type 5 P-type ATPase. Recently, we identified novel compound heterozygous mutations, c.3176T4

Spectrum of mutations and sequence varia
Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome
✍ Anna Sillén; Ingrun Anton-Lamprecht; Cordula Braun-Quentin; Cornelia S. Kraus; B 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 2 views

The gene encoding the human fatty aldehyde dehydrogenase (FALDH) is located on 17p11.2, causing Sjögren-Larsson syndrome (SLS) when mutated. SLS is an autosomal recessive disorder characterized by a combination of mental retardation, congenital ichthyosis, and spastic di-or tetraplegia. We report he

Further clinical delineation of the Börj
Further clinical delineation of the Börjeson–Forssman–Lehmann syndrome in patients with PHF6 mutations
✍ Melissa T. Carter; David J. Picketts; Alasdair G. Hunter; Gail E. Graham 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract Börjeson–Forssman–Lehmann syndrome is an X‐linked condition caused by __PHF6__ mutations. The classical description of males with this disorder includes severe intellectual disability with epilepsy, microcephaly, short stature, obesity, hypogonadism, and gynecomastia. We present three m

The spectrum of apoptotic defects and cl
The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations
✍ Akshay K. Vaishnaw; Elias Toubi; Satomi Ohsako; Jorn Drappa; Saundra Buys; Jaime 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 2 views

## Objective: To determine the clinical spectrum of disease in humans with mutations in the cd95 (fas/ apo-1) receptor and to obtain mechanistic insight into the different clinical phenotypes observed. ## Methods: Clinical information for each of the index cases, first-degree relatives, and any f

CARD15 mutations in familial granulomato
CARD15 mutations in familial granulomatosis syndromes: A study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy
✍ Xiaoju Wang; Helena Kuivaniemi; Gina Bonavita; Lysette Mutkus; Ulrike Mau; Edwar 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## Abstract ## Objective To analyze the __CARD15__ gene in families with heritable multi‐organ granulomatoses, including the original Blau syndrome kindred as well as other families with related granulomatous conditions. ## Methods Linkage mapping was performed in 10 families. Observed recombina